Abstract:Background Vasculogenic mimicry (VM) refers to the direct formation of microcirculatory ducts by invasive malignant tumors via cellular phenotypic transformation. However, there is a lack of VM‐based biomarkers for breast cancer. Methods We obtained transcriptomic expression data, single cell sequencing data, and clinical data of patients from The Cancer Genome Atlas Program (TCGA) database and GEO database, performed single cell analysis to obtain specific type annotations of breast cancer cells and analyzed their spatial expression analysis. Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene ontology (GO) analyses as well as Gene Set Enrichment Analysis (GSEA) analyses were performed to clarify the biological pathways and tumor functional enrichment relationships of the major expressed genes of VM in the breast cancer bulk data specimens. VM biomarkers were constructed. Meanwhile, the relationship between VM scores and tumor immune infiltration in breast cancer was analyzed using MCPcounter and ssGSEA methods. In addition, we assessed the specific relationship between NDRG1, a key VM gene in breast cancer, and tumor colonization, adhesion and invasion by biological experiments in breast cancer cell lines. Results The main cell types of breast cancer (BRCA) samples were annotated by single cell transcriptome analysis. Most of the VM‐high group was present in epithelial cells, whereas the VM‐low group was present in immune and stromal cells. Multiple tumor pathways such as TGFβ p53 and MAPK were closely associated with VM‐mediated breast cancer infiltration and invasion. A prognostic model of breast cancer based on VM key genes was constituted. Prognostic stratification of breast cancer was successfully achieved for the TCGA‐BRCA and GSE58812 datasets. Through immune infiltration analysis, we found that differential expression of VM markers was associated with multiple immune cell regulation. In MDA‐MB‐231 and MDA‐MB‐453 cell lines, we found that the NDRG1 gene significantly promoted colony formation of breast cancer cells. Conclusion Our constructed VM‐related gene‐based model of breast cancer biology holds promise for prognostic prediction and patient stratification of breast cancer. This may provide a potentially clinically valuable aid in promoting a deeper understanding of the biological regulation of VM in breast cancer and exploring the specific mechanisms of tumor angiogenesis and breast cancer development.

Status and prospect of vascular mimicry in cancer research

The driving mechanism and targeting value of mimicry between vascular endothelial cells and tumor cells in tumor progression

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments

Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets

Expression of vasculogenic mimicry in breast carcinoma and its significance

Vasculogenic mimicry regulates immune infiltration and mutational status of the tumor microenvironment in breast cancer to influence tumor prognosis

Vascular mimicry as a facilitator of melanoma brain metastasis

Anti-angiogenic Therapy for Tumor: Tumor Angiogenesis, Vasculogenic Mimicry and Vascular Normalization

Prognostic Value of Vascular Mimicry in Patients with Urothelial Carcinoma of the Bladder after Radical Cystectomy.

VEGF Induce Vasculogenic Mimicry of Choroidal Melanoma through the PI3k Signal Pathway

Cancer Immunotherapy with "Vascular-Immune" Crosstalk as Entry Point: Associated Mechanisms, Therapeutic Drugs and Nano-Delivery Systems

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

Identification of new subtypes of breast cancer based on vasculogenic mimicry related genes and a new model for predicting the prognosis of breast cancer

Deciphering breast cancer prognosis: a novel machine learning-driven model for vascular mimicry signature prediction

Effect of transcatheter arterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor in cervical squamous cell carcinoma

Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment

Engineered in vivo and in vitro tumor model recapitulates vasculogenic mimicry signatures in melanoma

The application and research progress of anti-angiogenesis therapy in tumor immunotherapy

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts

Research Advance in Vascular Endothelial Growth Factor and Anti-Tumor

The Role of Modern Medical Imaging in Evaluation of Tumor Response to Vascular Targeting Therapy